MedTrace Logo

Continuous Measurement of Glymphatic Activity in the Human Brain During Sleep-Wake States

NCT06060054 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2023-12-29

No results posted yet for this study

Summary

This is a cross-over randomized study to validate the Sponsor investigational medical device against measurements of glymphatic function from MRI-based neuroimaging, EEG, blood biomarkers and cognitive tests in healthy older volunteers.

Conditions

  • Healthy

Interventions

DIAGNOSTIC_TEST

Device measurements

Overnight device measurements

Sponsors & Collaborators

  • University of Washington

    collaborator OTHER

  • Oregon Health and Science University

    collaborator OTHER

  • Applied Cognition

    lead INDUSTRY

Principal Investigators

  • Paul Dagum, MD PhD · Applied Cognition, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
50 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-11-01
Primary Completion
2023-05-10
Completion
2023-05-10
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06060054 on ClinicalTrials.gov